Martin Steven Robert 4
4 · APRICUS BIOSCIENCES, INC. · Filed May 24, 2013
Insider Transaction Report
Form 4
Martin Steven Robert
Chief Financial Officer
Transactions
- Purchase
Common Stock
2013-05-23$2.85/sh+20,000$57,000→ 20,000 total - Purchase
Common Stock Warrant
2013-05-23$2.85/sh+20,000$57,000→ 20,000 totalExercise: $3.40From: 2013-05-29Exp: 2018-05-29→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Purchase in accordance with the Underwriting Agreement, by and between Apricus Biosciences, Inc. and Lazard Capital Markets LLC, dated May 23, 2013.
- [F2]Each warrant is exercisable for 0.50 shares of common stock.